ORIGINAL RESEARCH article
Front. Microbiol.
Sec. Antimicrobials, Resistance and Chemotherapy
Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1567921
This article is part of the Research TopicInnovation in Tackling the Global Challenge of Eradicating Antibiotic-Resistant MicroorganismsView all 11 articles
Overall In Vitro, In Vivo, and In Silico Evaluation of Olea europaea and Ficus carica Leaf Extracts for Antimicrobial Activity Against Multidrug-Resistant Pathogens
Provisionally accepted- 1Department of Cytotechnology, Faculty of Biomedical Sciences of Microbiology, Faculty of Science, University of Benghazi, Benghazi, Libya
- 2Basic Medical Sciences program, Faculty of Medical and Health Sciences, Libyan International Medical University, Benghazi, Libya
- 3Department of Pathology, Faculty of Medicine, University of Benghazi, Benghazi, Libya
- 4Department of Microbiology, Faculty of Science, University of Benghazi, Benghazi, Libya
- 5Department of Molecular Diagnostics, Faculty of Biomedical Sciences, University of Benghazi, Benghazi, Libya
- 6Department of Pharmacognosy, Faculty of Pharmacy, University of Benghazi, Benghazi, Libya
- 7Children Hospital of Benghazi, Benghazi, Libya
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
IntroductionAntimicrobial resistance (AMR) represents a critical global health issue, prompting the urgent exploration of alternative plant-derived antimicrobial therapies. In this context, the present study evaluates the therapeutic efficacy and safety profiles of Olea europaea and Ficus carica leaf extracts against multidrug-resistant pathogens, integrating in vitro antimicrobial assays, in vivo toxicity assessments, and in silico modeling approaches.MethodsLeaf extracts from O. europaea and F. carica were prepared by solvent-based maceration using methanol, acetone, and distilled water. Their antimicrobial properties were evaluated through disk and well diffusion assays to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against clinically relevant pathogens. Toxicological assessments were performed in vivo using the BALB/c mice model, including histopathological examinations, hematological profiling, and biochemical analyses. A complementary in vitro toxicogenomic screening was conducted using a cell-based reporter assay to profile nuclear receptor signaling and cellular stress responses. Furthermore, computational modeling and molecular docking were employed to predict the possible interactions of selected phytochemicals with E. coli cytochrome c peroxidase.ResultsMethanolic extracts of O. europaea exhibited potent antimicrobial activity against multidrug-resistant isolates, whereas F. carica extracts showed minimal efficacy across all experimental contexts. In silico molecular docking analyses revealed high-affinity interactions between olive-derived phenolic compounds and E. coli cytochrome c peroxidase, suggesting a plausible mechanistic basis for the observed antibacterial effects. In vivo, toxicological evaluation in BALB/c mice administered aqueous formulations of the methanolic olive extract demonstrated dose-dependent hepatic and renal histopathological alterations, accompanied by dysregulation of the immunological profiles and elevated hepatic enzyme levels. These findings were consistent with outcomes from the cell reporter assays and computational toxicology models, which indicated potential nephrotoxic and immunotoxic risks at higher concentrations.DiscussionThese findings validate the promising antimicrobial activity of O. europaea and F. carica leaf extracts against multidrug-resistant pathogens. However, further investigations on precise dosage optimization and long-term safety evaluations are essential before these extracts are implemented in clinical practice.
Keywords: Olea europae, Ficus carica, Multidrug-resistant pathogens, solvent extraction, antimicrobial activities, Toxicological evaluation, histopatholog, in silico modeling and docking
Received: 28 Jan 2025; Accepted: 22 Apr 2025.
Copyright: © 2025 Aloriby, Elkawafi, Aldrsy, Sweker, Elabdeli, Elbarghathi, Benhasouna, El-Awamie, ELSHARIF, Alqabbasi, Alshalmani, Algazal and Bleiblo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Farag Bleiblo, Department of Microbiology, Faculty of Science, University of Benghazi, Benghazi, Libya
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.